These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34685570)

  • 1. Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism.
    Akyol S; Ugur Z; Yilmaz A; Ustun I; Gorti SKK; Oh K; McGuinness B; Passmore P; Kehoe PG; Maddens ME; Green BD; Graham SF
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
    Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
    J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulations of bioactive lipids and their receptors in postmortem Alzheimer's disease brains.
    Kurano M; Saito Y; Uranbileg B; Saigusa D; Kano K; Aoki J; Yatomi Y
    Front Aging Neurosci; 2022; 14():1066578. PubMed ID: 36570536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted lipidomics reveals progression of early Alzheimer's disease in APP/PS1 transgenic mice.
    Zhang X; Liu W; Zan J; Wu C; Tan W
    Sci Rep; 2020 Sep; 10(1):14509. PubMed ID: 32884056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
    J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.
    Han X; Rozen S; Boyle SH; Hellegers C; Cheng H; Burke JR; Welsh-Bohmer KA; Doraiswamy PM; Kaddurah-Daouk R
    PLoS One; 2011; 6(7):e21643. PubMed ID: 21779331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain.
    Tu J; Yin Y; Xu M; Wang R; Zhu ZJ
    Metabolomics; 2017 Nov; 14(1):5. PubMed ID: 30830317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer's disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry.
    Kim SH; Yang JS; Lee JC; Lee JY; Lee JY; Kim E; Moon MH
    J Chromatogr A; 2018 Sep; 1568():91-100. PubMed ID: 30007793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease.
    Huynh K; Lim WLF; Giles C; Jayawardana KS; Salim A; Mellett NA; Smith AAT; Olshansky G; Drew BG; Chatterjee P; Martins I; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Arnold M; Nho K; Saykin AJ; Baillie R; Han X; Kaddurah-Daouk R; Martins RN; Meikle PJ
    Nat Commun; 2020 Nov; 11(1):5698. PubMed ID: 33173055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals.
    Olund Villumsen S; Benfeitas R; Knudsen AD; Gelpi M; Høgh J; Thomsen MT; Murray D; Ullum H; Neogi U; Nielsen SD
    Front Immunol; 2021; 12():742736. PubMed ID: 35095835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
    Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
    J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes.
    Liu Y; Thalamuthu A; Mather KA; Crawford J; Ulanova M; Wong MWK; Pickford R; Sachdev PS; Braidy N
    Transl Psychiatry; 2021 Jun; 11(1):344. PubMed ID: 34092785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer's Disease.
    Bhawal R; Fu Q; Anderson ET; Gibson GE; Zhang S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
    Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C;
    Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease.
    Fonteh AN; Ormseth C; Chiang J; Cipolla M; Arakaki X; Harrington MG
    PLoS One; 2015; 10(5):e0125597. PubMed ID: 25938590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
    Kaya I; Brinet D; Michno W; Syvänen S; Sehlin D; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2017 Feb; 8(2):347-355. PubMed ID: 27984697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional Lipidomics in Alzheimer's Disease.
    Kalli E
    Adv Exp Med Biol; 2020; 1195():95-104. PubMed ID: 32468464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease Risk Genes and Lipid Regulators.
    El Gaamouch F; Jing P; Xia J; Cai D
    J Alzheimers Dis; 2016 Apr; 53(1):15-29. PubMed ID: 27128373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.